knowledge -WSS

knowledge

author：fashion 2025-09-28 02:27:51 - browse：6887

The U.S. Department of Labor claims in a new lawsuit that a UnitedHealth Group unit illegally rejected emergency room care and urine drug screen claims for thousands of people.

UMR, Inc., a Wisconsin-based third-party administrator owned by UnitedHealth, manages benefits for more than 2,100 employee health plans. The federal government says the company denied ER visits and urine drug screens for years using a process that didn’t meet federal standards for health plans that employers fund themselves, known as self-insured plans. The standards are part of a law called the Employee Retirement Income Security Act, or ERISA.

“I see it as significant because the Department of Labor is actually looking under the hood at the standards and methods that insurers apply when they decide whether or not to approve or deny a claim,” said Colleen Medill, a professor at the University of Nebraska College of Law and nationally recognized legal scholar on ERISA. “They are looking at their process.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Pfizer, Moderna say biotech, pharma drug development is a sprint

WSS

Pumping milk in bathrooms at health conferences is common

Maisha Meds is a PBM, but don't call it that

Dana Farber says 6 studies to be retracted and 31 corrected

With Wegovy coverage, Medicare patients may face high costs

Diabetes management: Digital health tools fall short, study says

Biotech investment managers search for lucrative opportunities

hotspot

knowledge

entertainment

After affirmative action ruling, medical educators look to 'holistic review'

HPV vaccine, cervical cancer study delivers historic results

After affirmative action ruling, medical educators look to 'holistic review'

With Wegovy coverage, Medicare patients may face high costs

Virginia high school admissions case could be legal follow

Maisha Meds is a PBM, but don't call it that

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The inclusion problem at the heart of rehabilitation research

Walensky prepares to leave CDC — and Congress — behind

What Kate Middleton's cancer revelation might teach the world

Wikipedia

Pfizer, Moderna say biotech, pharma drug development is a sprint

Readout Newsletter: Illumina, CRISPR, Regeneron

With Wegovy coverage, Medicare patients may face high costs

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Immunocompromised patients offer clues on chronic Covid

CVS is on a mission to consolidate health care. Will it work?

focus

hotspot

entertainment

Wikipedia